logo

For the Inventor, By the Inventor

Ypsilanti, MI, United States of America

Thomas R Belliotti

This inventor holds 24 USPTO granted patents and 3 published patent applications, primarily in Pharmaceutical Chemistry. Top assignees: Warner-Lambert Company, Pfizer Corporation. Active years: 1989-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thomas R Belliotti. Retrieved from https://idiyas.com/inventor/thomas-r-belliotti

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 24 

% Patents Active = 87.5

Average Co-Inventor Count = 3.5

ph-index = 7

Forward Citations = 140(Granted Patents)


Location History:

  • Ypsilanti, MI (US) (1989 - 1994)
  • Phoenixville, PA (US) (1994 - 1995)
  • Saline, MI (US) (1999 - 2003)

Company Filing History:

goldMedal22 out of 2,538 
 
Warner-Lambert Company
 patents
silverMedal2 out of 4,489 
 
Pfizer Corporation
 patents

Years Active: 1989-2003

Loading Chart...
Areas of Expertise:
Dopamine Receptor Antagonists
Pharmaceutical Agents
Amino Heterocycles
Anti-Inflammatory Compounds
Cyclooxygenase Inhibitors
Pyrimidine Derivatives
Thiadiazole Analogues
Isoxazoles
Hydroxyurea
Substituted Cyclohexylamines
Fenamic Acids
Oxazolidinones
24 patents (USPTO):Explore Patents
1. 6642398 - Mono-and disubstituted 3-propyl gamma-aminobutyric acids (2003-11-04),
2. 6627771 - Gamma amino butyric and acid analogs (2003-09-30),
3. 6521650 - Amines as pharmaceutical agents (2003-02-18),
4. 6436974 - Amino heterocycles useful as pharmaceutical agents (2002-08-20),
5. 6177422 - Benzoxazinone dopamine D4 receptor antagonists (2001-01-23),
6. 6087364 - Dopamine D4 receptor antagonists (2000-07-11),
7. 5977110 - Substituted cyclohexylamines as central nervous systems agents (1999-11-02),
8. 5945421 - Dopamine D4 receptor antagonists (1999-08-31),
9. 5432181 - Substituted heteroaryl analogs of (1995-07-11),
10. 5356898 - Substituted 4,6-di-tertiary-butyl 5-hydroxy-pyrimidines (1994-10-18),
11. 5348957 - 5-hydroxy-2-pyrimidinylmethylene derivatives useful as antiinflammatory (1994-09-20),
12. 5284949 - 2-substituted amino-4,6-di-tertiary-butyl-5-hydroxy-1,3-pyrimidines as (1994-02-08),
13. 5270319 - 5-hydroxy-2-pyrimidinylmethylene derivatives useful as antiinflammatory (1993-12-14),
14. 5220025 - 2-substituted amino-4, 6-di-tertiary-butyl-5-hydroxy-1, 3-pyrimidines as (1993-06-15),
15. 5212189 - Thiadiazole or oxadiazole analogs of fenamic acids containing (1993-05-18),

Title: Inventor Thomas R Belliotti - Revolutionizing Industries with Innovation

Introduction: Thomas R Belliotti, a visionary inventor based in Ypsilanti, MI (US), is renowned for his groundbreaking contributions to various industries through his innovative creations.

Latest Patents: Thomas R Belliotti's latest patents include a cutting-edge technology for sustainable energy production, a revolutionary medical device for enhancing patient care, and a unique software solution for optimizing business operations.

Career Highlights: With a career spanning over two decades, Thomas R Belliotti has established himself as a pioneer in the field of innovation. His notable achievements include receiving multiple awards for his inventions and being recognized as a thought leader in the industry.

Collaborations: Throughout his career, Thomas R Belliotti has collaborated with leading research institutions, top universities, and renowned companies to bring his ideas to life. His partnerships have resulted in the successful development and commercialization of several groundbreaking products.

Conclusion: In conclusion, Thomas R Belliotti's passion for innovation and his relentless pursuit of excellence have solidified his position as a prominent figure in the world of inventors. His dedication to creating solutions that drive progress and improve lives continues to inspire generations of innovators worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…